Review Article

The Efficacy of Guanxinning Injection in Treating Angina Pectoris: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 1

Characteristics of the included studies.

StudyNumber of authorsTrial date reportSample
size
Followup
(day)
Baseline comparisonAEOutcomes
measure
Treatment group dosageAngina

Chen 2009111001510SYM, ECGGXN 20 mL/d + CGAngina
Chen et al. 2011311001000SYMGXN 20 mL/d + CGAngina
Chen 200611621411SYM, ECGGXN 20 mL/d + CGAngina
Cheng and Zang 201021431410SYMGXN 30 mL/d + CGUnstable
Cheng et al. 201131761411SYM, ECGGXN 30 mL/d + CGAngina
Dong XP 200910100100.5SYMGXN 20 mL/dAngina
Fu and Meng 201120471010SYM, ECGGXN 20 mL/d + CGAngina
Fu et al. 201041561410SYM, ECGGXN 200 ml + CG + shenmaiyin 40 mlAngina
Gao et al. 200531601411SYM, ECGGXN 20 mL/dAngina
Gong et al. 200931851411SYM, ECGGXN 20 mL/d + xueshuantong 20 mlStable
He and Meng 200711491510SYMGXN 20 mL/d + CGUnstable
He 2009111202811SYM, ECGGXN 30 mL/d + atorvastatin 10 mgUnstable
Hou and Gao 2009211281411SYM, ECGGXN 20 mL/d + CGStable
Huang et al. 201140120711SYMGXN 20 mL/d + CG + xueshuantong 400 mgAngina
Jiang et al. 2010311161010SYM, ECGGXN 20 mL/d + CGUnstable
Jiang 200911682011SYM, ECGGXN 20 mL/dAngina
Jiang et al. 20105056701SYMGXN 30 mL/dAngina
Kong 2009101001411SYMGXN 30 mL/d + CGUnstable
Lan et al. 200631641411SYMGXN 20 mL/dAngina
Li and Jia 2011212001410SYM, ECGGXN 30 mL/d + CGAngina
Li and Lei 2005211561401SYM, ECGGXN 20 mL/d + CGAngina
Li et al. 2009511681410SYMGXN 20 mL/d + CGAngina
Li and Ran 2009211601011SYMGXN 20 mL/d + CGAngina
Li 20041083710SYM, ECGGXN 20 mL/d + CGUnstable
Liang and Feng 2010201201410SYM, ECGGXN 20 mL/d + CGUnstable
Liu 2004111041011SYMGXN 20 mL/d + CGUnstable
Liu and Li 200721881201SYMGXN 20 mL/d + CGUnstable
Liu 200511803010SYM, ECGGXN 20 mL/d + CGUnstable
Liu 2011111522810SYM, ECGGXN 20 mL/d + CGAngina
Lu et al. 200631683010SYMGXN 30 mL/d + CGAngina
Ma and Peng 2008211201410SYMGXN 30 mL/d + CGUnstable
Nie and Chen 200721601410SYM, ECGGXN 20 mL/d + CGAngina
Qiao and Wu 200420812811SYM, ECGGXN 20 mL/d + CGStable
Song 20101182700.5SYMGXN 20 mL/d + CG + diltiazem 90 mg/dUnstable
Su 200911901501SYM, ECGGXN 6 mL/d + CGAngina
Sun 201011901410SYM, ECGGXN 30 mL/d + CGUnstable
Sun et al. 200651981500SYMGXN 20 mL/d + CGAngina
Tian and Wu 200621621411SYMGXN 30 mL/d + CGUnstable
Wan and Xu 2009201201411SYM, ECGGXN 30 mL/d + CGUnstable
Wang 2007111001411SYM, ECGGXN 30 mL/d + CGAngina
Wang 201111851411SYM, ECGGXN 20 mL/d + CGUnstable
Wang 2011211121411SYM, ECGGXN 20 mL/d + CGUnstable
Wang and Ji 200821601400SYM, ECGGXN 20 mL/d + CGUnstable
Wang and Sun 200721921000SYMGXN 20 mL/d + CGUnstable
Wang 200521601510SYMGXN 20 mL/d + CGUnstable
Wang 201010801411SYM, ECGGXN 20 mL/d + CGStable
Wang 200510761500SYMGXN 20 mL/d + CG + shenmai 30 mL/d + tongxinluo 9 pills/dUnstable
Wang 200511601411SYMGXN 20 mL/d + CGUnstable
Wang et al. 201141601411SYMGXN 20 mL/d + CGUnstable
Wu et al. 2008301081410SYMGXN 20 mL/d + CGAngina
Wu et al. 201141144710SYMGXN 20 mL/d + CG + shenmai 50 mL/dUnstable
Xia 201111901410SYM, ECGGXN 30 mL/d + CGUnstable
Yang and Ma 200821901410SYM, ECGGXN 30 mL/d + CGUnstable
Ye et al. 200830761501SYMGXN 20 mL/d + CGUnstable
Yu and Wang 200921751510SYM, ECGGXN 20 mL/d + CGAngina
Yuan 2005101041410SYM, ECGGXN 20 mL/d + CGAngina
Zhang 200511601410SYM, ECGGXN 10 mL/dAngina
Zhang 2010112401511SYM, ECGGXN 20 mL/d + CGUnstable
Zhang 2004111021411SYM, ECGGXN 10 mL/d + CG + ginkgo leaf injection 10 mL/dAngina
Zhang 20041142701SYMGXN 20 mL/d + CGAngina
Zhao et al. 2010611001411SYM, ECGGXN 10 mL/d + CG + xueshuangtong 120 mgUnstable
Zhao and An 200821902811SYM, ECGGXN 20 mL/d + CG + simvastatin 10–20 mg/dUnstable
Zhao 201011861410SYM, ECGGXN 30 mL/d + CGAngina
Zhong et al. 200781601000SYMGXN 20 mL/d + CGAngina
Zhu 200511801500.5SYM, ECGGXN 20 mL/d + CGUnstable

GXN is Guanxinning injection; LMWH is low molecular weight heparin; and shenmai is Shenmai injection. CG is interventions of control group; SYM is SYMPTOMS; ECG is electrocardiogram; and AE is adverse event. The column of “Trial date report” shows that study did (1) or did not (0) report the trial date. The column of “Baseline comparison” shows that the study did (1) or did not (0) report the baseline comparison between the treatment and control groups.